|
In EUR m
|
Q1 2024
|
Q1 2023
|
|
Revenue
|
453.4
|
409.9
|
|
EBITDA (adjusted)
|
108.4
|
97.2
|
|
Exceptional items
|
-4.7
|
-2.8
|
|
EBITDA
|
103.8
|
94.4
|
|
Amortization, depreciation and impairment
|
-76.9
|
-76.0
|
|
thereof attributable to purchase price allocations and impairment losses
|
-3.2
|
-4.9
|
|
EBIT
|
26.9
|
18.3
|
|
Net finance income/costs
|
-18.3
|
-13.6
|
|
EBT
|
8.6
|
4.7
|
|
Taxes
|
-2.6
|
-1.3
|
|
Consolidated profit or loss for the period
|
6.0
|
3.4
|
|
Adjusted consolidated profit or loss for the period
|
12.5
|
8.9
|
|
Free cash flow (before M&A transactions)
|
24.6
|
21.2
|
|
Free cash flow (before M&A transactions)(Adjusted)
|
-24.4
|
-14.5
|
|
Net debt (Mar. 31/Dec. 31)
|
782.8
|
770.0
|
